Ayurcann Holdings Corp.
AYURF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,049 | $4,820 | $4,902 | $4,536 |
| - Cash | $840 | $1,986 | $1,080 | $1,333 |
| + Debt | $668 | $711 | $2,744 | $1,030 |
| Enterprise Value | $7,876 | $3,546 | $6,566 | $4,233 |
| Revenue | $6,087 | $7,745 | $7,558 | $7,502 |
| % Growth | -21.4% | 2.5% | 0.7% | – |
| Gross Profit | $1,539 | $1,502 | $2,579 | $3,272 |
| % Margin | 25.3% | 19.4% | 34.1% | 43.6% |
| EBITDA | -$569 | -$2,266 | -$208 | $318 |
| % Margin | -9.3% | -29.3% | -2.7% | 4.2% |
| Net Income | -$793 | -$1,910 | -$562 | -$122 |
| % Margin | -13% | -24.7% | -7.4% | -1.6% |
| EPS Diluted | -0.004 | -0.01 | -0.003 | -0.001 |
| % Growth | 58.2% | -237.9% | -383.3% | – |
| Operating Cash Flow | -$1,066 | $805 | $332 | $622 |
| Capital Expenditures | -$11 | -$9 | -$2 | -$42 |
| Free Cash Flow | -$1,077 | $796 | $330 | $579 |